Unraveling the role of heavy metals xenobiotics in cancer: a critical review
Open Access
- 4 November 2024
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-25
Abstract
Cancer is a multifaceted disease characterized by the gradual accumulation of genetic and epigenetic alterations within cells, leading to uncontrolled cell growth and invasive behavior. The intricate interplay between environmental factors, such as exposure to carcinogens, and the molecular cascades governing cell growth, differentiation, and survival contributes to cancer’s development and progression. This review offers a comprehensive overview of key molecular targets and their roles in cancer development. Peroxisome proliferator-activated receptors are implicated in various cancers due to their role in regulating lipid metabolism, inflammation, and cell proliferation. Nuclear factor erythroid 2-related factor 2 protects cells from oxidative damage but can also promote tumor cell survival. Cytochrome P450 1B1 metabolizes exogenous and endogenous substances, and its increased expression is observed in several cancers. The constitutive androstane receptor regulates gene expression, and its dysregulation can lead to liver cancer. Transforming growth factor-beta 2 is involved in the development and progression of various cancers by dysregulating cell proliferation, differentiation, and migration. Chelation treatment has been investigated for removing heavy metals, while genetically altered immune cells show promise in treating specific cancers. Metal–organic frameworks and fibronectin targeting represent new directions in cancer treatment. While some heavy metals, such as arsenic, chromium, nickel, and cadmium, are known to have carcinogenic properties, others, like zinc, Copper, gold, bismuth, and silver, have many uses that highlight their potential as effective cancer control tactics. There are a variety of heavy metal-based technologies that show potential for improving cancer treatment methods, including targeted drug delivery, improved radiation, and diagnostic tools. Graphical AbstractKeywords
This publication has 167 references indexed in Scilit:
- Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case‐control studies (SYNERGY)International Journal of Cancer, 2022
- The role of bile acids in carcinogenesisCellular and Molecular Life Sciences, 2022
- The multidimensional role of the Wnt/β‐catenin signaling pathway in human malignanciesJournal of Cellular Physiology, 2021
- Recent aspects of the effects of zinc on human healthArchives of Toxicology, 2020
- Nrf2–ARE signaling in cellular protection: Mechanism of action and the regulatory mechanismsJournal of Cellular Physiology, 2019
- Proteomic characterization of arsenic and cadmium exposure in bladder cellsRapid Communications in Mass Spectrometry, 2019
- Transforming growth factor β signaling pathway: A promising therapeutic target for cancerJournal of Cellular Physiology, 2019
- Extracellular‐signal‐regulated kinase/mitogen‐activated protein kinase signaling as a target for cancer therapy: an updated reviewCell Biology International, 2019
- The crosstalk between trace elements with DNA damage response, repair, and oxidative stress in cancerJournal of Cellular Biochemistry, 2018
- Epigenetics of breast cancer: Modifying role of environmental and bioactive food compoundsMolecular Nutrition & Food Research, 2016